Autosomal dominant tubulointerstitial kidney disease (ADTKD) is a group of inherited conditions that affect the tubules of the kidneys, causing the kidneys to gradually lose their ability to work.
ADTKD; Medullary cystic kidney disease; Renin associated kidney disease; Familial juvenile hyperuricemic nephropathy; Uromodulin associated kidney disease
ADTKD is caused by mutations in certain genes. These gene problems are passed down through families (inherited) in an autosomal dominant pattern. This means the abnormal gene is needed from only one parent in order to inherit the disease. Often, many family members have the disease.
With all forms of ADTKD, as the disease progresses, the kidney tubules are damaged. These are the structures in the kidneys that allow most water in the blood to be filtered and returned to the blood.
Their abnormal genes that cause the different forms of ADTKD are:
When the cause of ADTKD is not known or a genetic test has not been done, it is called ADTKD-NOS.
Early in the disease, depending on the form of ADTKD, symptoms may include:
As the disease worsens, symptoms of kidney failure may develop, which include:
There is no cure for ADTKD. At first, treatment focuses on controlling symptoms, reducing complications, and slowing the progression of the disease. Because so much water and salt are lost, you will need to follow instructions on drinking plenty of fluids and taking salt supplements to avoid dehydration.
As the disease progresses, kidney failure develops. Treatment may involve taking medicines and diet changes, limiting foods containing phosphorus and potassium. You may need dialysis and a kidney transplant.
Petr Vyletal practices in Prague, Czech Republic. Vyletal is rated as an Elite expert by MediFind in the treatment of Autosomal Dominant Tubulointerstitial Kidney Disease. He is also highly rated in 1 other condition, according to our data. His top areas of expertise are Autosomal Dominant Tubulointerstitial Kidney Disease, Chronic Kidney Disease, Polycystic Kidney Disease, Autosomal Dominant Polycystic Kidney Disease, and Kidney Transplant.
Luca Rampoldi practices in Milan, Italy. Rampoldi is rated as an Elite expert by MediFind in the treatment of Autosomal Dominant Tubulointerstitial Kidney Disease. He is also highly rated in 5 other conditions, according to our data. His top areas of expertise are Autosomal Dominant Tubulointerstitial Kidney Disease, Interstitial Nephritis, Nephrogenic Diabetes Insipidus, and Polycystic Kidney Disease.
Eric Olinger practices in Zurich, Switzerland. Olinger is rated as an Elite expert by MediFind in the treatment of Autosomal Dominant Tubulointerstitial Kidney Disease. He is also highly rated in 4 other conditions, according to our data. His top areas of expertise are Autosomal Dominant Tubulointerstitial Kidney Disease, Polycystic Kidney Disease, Autosomal Dominant Polycystic Kidney Disease, and Congenital Hepatic Fibrosis.
The age at which people with ADTKD reach end-stage kidney disease varies, depending on the form of the disease. It can be as young as in the teens or in older adulthood. Lifelong treatment may control the symptoms of chronic kidney disease.
ADTKD may lead to the following health problems:
Contact your provider if you have any symptoms of urinary or kidney problems.
Medullary cystic kidney disease is an inherited disorder. It may not be preventable.
Published Date: July 27, 2021
Published By: Walead Latif, MD, Nephrologist and Clinical Associate Professor, Rutgers Medical School, Newark, NJ. Review provided by VeriMed Healthcare Network. Also reviewed by David Zieve, MD, MHA, Medical Director, Brenda Conaway, Editorial Director, and the A.D.A.M. Editorial team.
Eckardt KU, Alper SL, Antignac C, et al. Autosomal dominant tubulointerstitial kidney disease: diagnosis, classification, and management--a KDIGO consensus report. Kidney Int. 2015;88(4):676-683. PMID: 25738250 pubmed.ncbi.nlm.nih.gov/25738250/.
Guay-Woodford LM. Other cystic kidney diseases. In: Feehally J, Floege J, Tonelli M, Johnson RJ, eds. Comprehensive Clinical Nephrology. 6th ed. Philadelphia, PA: Elsevier; 2019:chap 45.
Torres VE, Harris PC. Cystic diseases of the kidney. In: Yu ASL, Chertow GM, Luyckx VA, Marsden PA, Skorecki K, Taal MW, eds. Brenner and Rector's The Kidney. 11th ed. Philadelphia, PA: Elsevier; 2020:chap 45.